THE RAND CORPORATION - ANALYSIS RELATED TO MEDICARE ADVANTAGE AND PART D CONTRACT STAR RATING

PIID: 75FCMC22F0074

Effective Date: Sep 15, 2022End Date: Closes in 150 days

Key Details

Dollars Obligated

$10.2M

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

Centers for Medicare and Medicaid Services

Description

ANALYSIS RELATED TO MEDICARE ADVANTAGE AND PART D CONTRACT STAR RATING

Contractor Information

Contractor: THE RAND CORPORATION

Similar Awards

VACCINES FOR CHILDREN FY25

MERCK SHARP & DOHME LLC

$2.5B

VACCINES FOR CHILDREN FY25

SANOFI VACCINES US INC.

$1.4B

TAS::75 0140::TAS CONSTRUCTION OF VACCINE MANUFACTURING FACILITY

SEQIRUS INC

$1.3B

VACCINES FOR CHILDREN FY25

SANOFI VACCINES US INC.

$1.3B

VACCINES FOR CHILDREN FY25

SANOFI VACCINES US INC.

$1.3B

View Full Record on USASpending.gov

View on USASpending

See the full award record on USASpending.gov

Learn more

Track This Award

Get alerts on modifications and recompete opportunities

Learn more

Analyze with AI

AI-powered competitive intelligence analysis

Learn more

Stay Updated

Get notified about new opportunities matching your interests.

Agencies

Department of Health and Human Services

Vendors

THE RAND CORPORATION

THE RAND CORPORATION - ANALYSIS RELATED TO MEDICARE ADVANTAGE AND PART D CONTRACT STAR RATING

Key Details

Description

Contractor Information

Similar Awards

View on USASpending

Track This Award

Analyze with AI

Stay Updated

Related